This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre Regional De Lutte Contre Le Cancer Francois Baclesse, Institut De Cancerologie De L'ouest Rene Gauducheau, Université De Caen Basse Normandie. Active years: 2019.
Company Filing History:
1 out of 2 
1 out of 1 
1 out of 13 Years Active: 2019
Title: Fabien Gautier: Innovator in Cancer Treatment
Introduction
Fabien Gautier is a notable inventor based in Angers, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds.
Latest Patents
Gautier holds a patent for "Mcl-1 modulating compounds for cancer treatment." This invention relates to compounds of formula (I) and their therapeutic use in the treatment of cancer. His work in this area demonstrates a commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Fabien Gautier has worked with esteemed organizations such as the Centre Régional de Lutte Contre Le Cancer François Baclesse and Université de Caen Basse Normandie. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Gautier has collaborated with notable colleagues, including Laurent Poulain and Anne-Sophie Voisin-Chiret. These partnerships have enriched his work and expanded the impact of his inventions.
Conclusion
Fabien Gautier's contributions to cancer treatment through his innovative patents and collaborations highlight his dedication to improving healthcare. His work continues to inspire advancements in medical research and therapeutic development.